1. A Rodent Model of Sulfur Mustard Hematologic Toxicity for the Efficacy Evaluation of Candidate Medical Countermeasures
- Author
-
David T. Yeung, Jill A. Harvilchuck, Gennady E. Platoff, Christina M. Wilhelm, and Phillip H Beske
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Physiology ,Rodentia ,Neutropenia ,Feature Article and Original Research ,Rats, Sprague-Dawley ,Blood cell ,03 medical and health sciences ,Lethargy ,0302 clinical medicine ,Immune system ,Internal medicine ,Mustard Gas ,medicine ,Animals ,Humans ,Chemical Warfare Agents ,Hematology ,Respiratory distress ,Public Health, Environmental and Occupational Health ,General Medicine ,medicine.disease ,Rats ,030104 developmental biology ,medicine.anatomical_structure ,Medical Countermeasures ,Toxicity ,030221 ophthalmology & optometry ,Female ,Bone marrow - Abstract
Introduction While exposure to sulfur mustard (SM) is commonly associated with the production of vesicating dermal, ocular, and respiratory injuries, systemic damage to bone marrow and lymphatic tissue can decrease critical immune cell populations leading to higher susceptibility to life-threatening infection and septicemia. There are currently no approved medical countermeasures for SM-induced myelosuppression. An intravenous SM challenge model was developed in adult rats as a preliminary proof-of-principle platform to evaluate the efficacy of candidate immunostimulants. Materials and Methods Adult male and female Sprague Dawley rats were exposed to SM through tail vein injection. Toxicity progression was monitored through clinical observations, body weights, body temperatures, hematology, serum clinical chemistry, and flow cytometry of blood and bone marrow samples. Results Following SM exposure, overt toxicity progression was characterized by weight loss, changes in body temperature, and manifestation of toxic clinical signs (diarrhea, lethargy, hunched posture, rough hair coat, respiratory distress, and death). Drastic alterations in complete blood cell profiles included an early-onset lymphopenia followed by a delayed-onset neutropenia and thrombocytopenia. Only transient changes in serum clinical chemistry parameters were observed. Flow cytometry analysis of circulating blood revealed that B-cells were more predominantly affected by SM exposure than T-cells. Challenge with SM resulted in loss of hematopoietic and mesenchymal stem cell populations in the bone marrow. Conclusions The small animal model developed in this study replicates many key aspects of human SM exposures and should serve as a relevant, rapid, and cost-effective platform to screen candidate medical countermeasures for SM-induced hematologic toxicity.
- Published
- 2022
- Full Text
- View/download PDF